Dr. Yu-Tze Ng
Lawrence, Kansas
Dr. Yu-Tze Ng is not just a wonderful clinician but also a very prominent clinical educator and researcher within the child neurology and epilepsy communities. He is a true physician clinician scientist and educator who has mentored many residents, medical students and junior colleagues to date.
As a teacher, he began the first of many teaching awards even during his Epilepsy Fellowship when he was awarded the Certificate of Appreciation for Excellence in Teaching to the neurology residents at the University of Texas-Houston. Subsequently he won the Outstanding Faculty Teaching Award to Pediatric Education, 2012-2013 from the Department of Pediatrics, University of Oklahoma. He was then nationally recognized by winning the A.B. Baker Teaching Award from the American Academy of Neurology this year in 2016. This was subsequently followed by The Children’s Hospital of San Antonio’s first year of residents recognizing outstanding faculty teachers, where he won one of only five Superstar Faculty Awards, “Most Likely to Turn Heads”! In 2023 he won a Legacy Teaching Award from a medical student and the patient’s family at The University of Columbia Medical School. He has always and constantly continues to receive outstanding teaching reviews from medical students, residents and fellows alike.
Other awards that he has won include, the Texas Neurological Society, Young Investigator Award. He then also won the Journal of Child Neurology/Decker Publishing Neuroscience prize two years in a row at the Southern Pediatric Neurology Society. He has been made a distinguished Fellow of the American Academy of Neurology (FAAN), American Academy of Pediatrics (FAAP) and American Epilepsy Society (FAES).
He has published well over 100 journal articles of which the vast majority are peer-reviewed. He was the first author in nearly all of the first half of his publications followed by being the senior author in the later half. He has several publications in the prestigious journal, Neurology where he was the first author in two major papers; the largest study in Lennox-Gastaut syndrome involving clobazam and another regarding the treatment of hypothalamic hamartomas. He has even published a commentary in the New England Journal of Medicine. He was on the Editorial Boards of three pediatric journals, i.e. the Journal of Child Neurology, Journal of Pediatrics and Child Health and Pediatric Neurology. He subsequently resigned from the former two journals when he was invited to become only one of three Associate Editors by the Editor-in-Chief for Pediatric Neurology.
He has been the primary investigator (PI) in well over 10 multi-center clinical drug trials and in fact been the main recruiter and first author in a couple of them. Previously he was the only PI granted funding from UCB Pharmaceuticals Inc., for his investigator-initiated study for the use of intravenous levetiracetam in children when this now very popular drug was first being launched. In his short time here with us he is already participating as the PI in four drug studies having already recruited patients. He and The Children’s Hospital of San Antonio were selected as the only site in Texas to be part of a world multi-center clinical drug trial on cannabinoid treatment of infantile spasms. He has also partnered with the local Epilepsy Foundation of San Antonio and Texas to apply for grants to enhance outreach and telemedicine to enhance the care of epilepsy in children living in remote areas of Texas.
After more than seven years as the inaugural Pediatric Neurology Endowed Chair Holder and Professor of Pediatrics (with Tenure) as well as the Neurology Chief at The Children’s Hospital of San Antonio he entered private practice in 2021. Unlike many academic clinicians however, Dr. Ng has always seen many patients with excellent diagnostic and therapeutic outcomes and patient satisfaction scores. His areas of (world-renowned) expertise predominantly involve various treatments of epilepsy with the latest drug and surgical therapies. His areas of expertise include: Lennox-Gastaut syndrome, (neurosurgery for) status epilepticus, antiepileptic drugs and hypothalamic hamartomas. Hence he has been invited and delivered well over 50 lectures as a visiting professor or indeed keynote speaker (including a National Epilepsy Conference in China and two pharmaceutical meetings in Japan) all over the country and world.
In terms of administrative duties, Dr. Ng was a former President (now CFO) of the Southern Pediatric Neurology Society served on the Scientific Review Committees for the Child Neurology Society (CNS), and recently American Epilepsy Society (AES) and is on the Child Neurology and Epilepsy Sections of the AAN. He was previously nominated by the CNS as a candidate for the Councilor for the South.